Paclitaxel: A Pharmacoeconomic Review of its Use in the Treatment of Ovarian Cancer

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.19, Iss.12, 2001-01, pp. : 1227-1259

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Paclitaxel: A Pharmacoeconomic Review of its Use in Non-Small Cell Lung Cancer

By Plosker G.L. Hurst M.

PharmacoEconomics, Vol. 19, Iss. 11, 2001-11 ,pp. : 1111-1134

Adis International

Access to resources Recommend Favorite

Docetaxel: A Pharmacoeconomic Review of its Use in the Treatment of Metastatic Breast Cancer

By Lamb H.M. Wiseman L.R.

PharmacoEconomics, Vol. 14, Iss. 4, 1998-10 ,pp. : 447-459

Adis International

Access to resources Recommend Favorite

Cefotaxime: A Pharmacoeconomic Review of its Use in the Treatment of Infections

By Plosker G.L. Foster R.H. Benfield P.

PharmacoEconomics, Vol. 13, Iss. 1 Part 2, 1998-01 ,pp. : 91-106

Adis International

Access to resources Recommend Favorite

Paclitaxel: An Update of its Use in the Treatment of Metastatic Breast Cancer and Ovarian and Other Gynaecological Cancers

By Wiseman L.R. Spencer C.M.

Drugs & Aging, Vol. 12, Iss. 4, 1998-04 ,pp. : 305-334

Adis International

Access to resources Recommend Favorite

Trastuzumab: A Pharmacoeconomic Review of its Use in Early Breast Cancer

By McKeage Kate Lyseng-Williamson Katherine A.

PharmacoEconomics, Vol. 26, Iss. 8, 2008-01 ,pp. : 699-719

Adis International

Access to resources Recommend Favorite